Soligenix, Inc. (SNGX)
NASDAQ: SNGX · Real-Time Price · USD
1.140
-0.010 (-0.87%)
At close: Apr 2, 2026, 4:00 PM EDT
1.140
0.00 (0.02%)
Pre-market: Apr 6, 2026, 9:06 AM EDT
Soligenix Market Cap
Soligenix has a market cap or net worth of $11.75 million as of April 6, 2026. Its market cap has increased by 102.57% in one year.
Market Cap
11.75M
Enterprise Value
4.17M
1-Year Change
102.57%
Ranking
Category
Stock Price
$1.14
Market Cap Chart
Since December 1, 1998, Soligenix's market cap has decreased from $24.80M to $11.75M, a decrease of -52.63%. That is a compound annual growth rate of -2.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 11.70M | -13.33% |
| Dec 31, 2025 | 13.50M | 98.53% |
| Dec 31, 2024 | 6.80M | -13.92% |
| Dec 29, 2023 | 7.90M | -59.49% |
| Dec 30, 2022 | 19.50M | -31.10% |
| Dec 31, 2021 | 28.30M | -25.92% |
| Dec 31, 2020 | 38.20M | 27.76% |
| Dec 31, 2019 | 29.90M | 96.71% |
| Dec 31, 2018 | 15.20M | -21.65% |
| Dec 29, 2017 | 19.40M | 128.24% |
| Dec 30, 2016 | 8.50M | -72.40% |
| Dec 31, 2015 | 30.80M | 42.59% |
| Dec 31, 2014 | 21.60M | -37.39% |
| Dec 31, 2013 | 34.50M | 414.93% |
| Dec 31, 2012 | 6.70M | 1.52% |
| Dec 30, 2011 | 6.60M | -83.90% |
| Dec 31, 2010 | 41.00M | -11.64% |
| Dec 31, 2009 | 46.40M | 660.66% |
| Dec 31, 2008 | 6.10M | -62.11% |
| Dec 31, 2007 | 16.10M | -2.42% |
| Dec 29, 2006 | 16.50M | 20.44% |
| Dec 30, 2005 | 13.70M | -49.07% |
| Dec 31, 2004 | 26.90M | -0.37% |
| Dec 31, 2003 | 27.00M | 167.33% |
| Dec 31, 2002 | 10.10M | -22.90% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 12.38M |
| Kairos Pharma | 12.10M |
| Cadrenal Therapeutics | 11.78M |
| CytoMed Therapeutics | 11.40M |
| Chemomab Therapeutics | 11.23M |
| PMGC Holdings | 11.08M |
| Imunon | 10.95M |
| Cellectar Biosciences | 10.81M |